For the most part, the healthcare sector has been heating up on the stock market as of late. Today’s trading session doesn’t appear to be any different. In fact, there are two healthcare stocks that have climbed more than 20% today. To top it off, the trading day isn’t even close to being over.
Without further adieu, here are 2 healthcare stocks making major waves today.
Tuesday, February 27: Healthcare Stocks on the Rise
- Akers Biosciences Inc. (NASDAQ:AKER) (LON:AKR)
Grabbing the number one spot on this list is Akers Biosciences Inc. Founded in 1989, Akers Biosciences focuses primarily on developing and manufacturing various screening and testing products that help to bring forward relevant health information to clinicians and their patients. Currently, the New Jersey-based company is soaring on both the American and the London stock market.
As of right now, on the Nasdaq Exchange, Akers Bioscience is trading at $0.77. This puts the AKER stock up $0.20, or 34.95%. On the London Stock Exchange, Akers Biosciences is up more than 40%.
- BioPharmX Corporation (NYSEAMERICAN:BPMX) (FRA:BPC)
BioPharmX Corporation has been in the healthcare game for more than 40 years. In this time, it has become a leading global design and construction provider of various biotechnology manufacturing systems and facilities. The company has remained innovative throughout its entire lifetime, even presenting new pieces of data at two leading clinical conferences last month. It is for these reasons I am not surprised to see the company soaring on the American and the German stock exchange.
Currently, on the NYSE American Exchange, BioPharmX Corporation is trading at $0.22, which puts the stock up $0.04, or 21.17%. The stock opened at $0.19 and has a market capitalization of 27.80 million. As for the Frankfurt Stock Exchange, BioPharmX Corporation can be seen trading up nearly 20%.
>>InspireMD Signs Distribution Agreement with South Korea
The Takeaway
Looking at the trending tickers of today’s trading session, it’s hard to ignore these two healthcare companies. It will be interesting to see if Akers and BioPharmX will be able to maintain a more than 20% growth throughout the rest of the week. If they do, I would suggest adding them to your watch-list.
Featured Image: Twitter
